首页|基于大鼠静脉注射盐酸千金藤素的暴露特征探讨其体内药理活性

基于大鼠静脉注射盐酸千金藤素的暴露特征探讨其体内药理活性

扫码查看
目的 建立液相色谱-串联质谱(LC-MS/MS)方法定量检测iv给予盐酸千金藤素后药物在大鼠血浆和组织中的含量及其随时间变化过程,依据千金藤素肺靶部位的有效暴露量和文献报道的体外抗冠状病毒活性探讨其体内药理活性。方法 ①建立测定大鼠血浆和组织匀浆中千金藤素含量的LC-MS/MS法。采用蛋白沉淀法处理血浆和组织匀浆样品;采用Phenomenex C18(3。0 mm×50 mm,2。6 μm)色谱柱,以0。05%甲酸-2 mmol·L-1乙酸铵-水溶液和0。1%甲酸-乙腈溶液为流动相梯度洗脱(流速0。6 mL·min-1);正离子多反应监测模式检测千金藤素(m/z:607。3→365。1)和内标丁螺环酮(m/z:386。4→122。2)。②6只SD大鼠单次iv给予盐酸千金藤素7。5 mg·kg-1后不同时间点采集血样,用LC-MS/MS法测定血药浓度,应用非房室模型计算药物消除半衰期(t1/2)、初始浓度(C0)、曲线下面积(AUC)、清除率(CL)和表观分布容积(V)等主要药动学参数。③72只SD大鼠随机分为2组,分别单次或多次(每24h1次,连续5d)iv给予盐酸千金藤素7。5 mg·kg-1,末次给药后0。033,0。25,4,24,72和120 h(n=6)行心脏穿刺采血,并采集组织样品,测定血浆和组织中千金藤素含量。④3只SD大鼠iv盐酸千金藤素(7。5 mg·kg-1)2 h后静脉采血测定千金藤素大鼠全血/血浆分配比(Rb/p)。⑤ 平衡透析法测定千金藤素在大鼠血浆及肺组织匀浆中蛋白结合率,计算肺游离药物浓度。结果 ①建立的LC-MS/MS法在2~1 000 μg·L-1范围内线性关系良好(r2>0。999),定量下限为2 μg·L-1,经方法学验证满足定量检测要求。②大鼠单次iv给予千金藤素7。5 mg·kg-1 后主要药动学参数:C0 为(686。91±238。43)μg·L-1,t1/2为(29。70±6。29)h,Vz为(62。70±7。93)L·kg-1,Vss为(62。55±11。28)L·kg-1,CL为(1。50±0。23)L·h-1·kg-1,AUC(0-t)为(4。52±0。61)h·mg·L-1。③单次及多次iv千金藤素7。5 mg·kg-1后,组织中浓度均高于血浆,肺组织含量最高,单次和多次iv给药的AUC(0-t)分别为(2 547。35±156。56)和(4 481。35±479。21)h·mg·L-1。④经测定千金藤素在大鼠中Rb/p=3。5±0。8,提示其在血细胞中含量高于血浆。⑤经蛋白结合率校正后,肺最低游离药物浓度(95。04 μg·L-1)高于文献报道的抗新型冠状病毒活性水平(EC50=60。67 μg·L-1)。结论 建立的LC-MS/MS方法可快速灵敏地定量大鼠血浆和肺组织中的千金藤素含量。iv给予盐酸千金藤素后药物的肺暴露量远远高于血浆及其他组织,为科学评估其体内药理活性提供了依据。
In vivo pharmacological efficacy of intravenously administered cepharanthine hydrochloride in rats based on its exposures
OBJECTIVE To establish a liquid chromatography massspectrometry(LC-MS/MS)method for quantitatively determining the concentration of cepharanthine in rat plasma and tissue samples after intravenous injection of cepharanthine hydrochloride.METHODS ①The LC-MS/MS method was adopted.A Phenomenex C18(3.0 mm×50 mm,2.6 μm)column was employed with a mobile phase consisting of 0.05%formic acid-2 mmol·L-1 ammonium acetate-water solution and 0.1%formic acid-acetonitrile solution under gradient elution at a flow rate of 0.6 mL·min-1.The determination was performed using positive ion multiple reaction monitoring mode assays:cepharanthine(m/z:607.3→365.1)and buspirone(IS)(m/z:386.4→122.2).② Blood samples were collected from 6 SD rats at different time points following a single iv administration of cepharanthine to determine the concentration of the drug.The main pharmacokinetic parameters were calculated using a non-compartmental model.③72 SD rats were subjected to tissue distribution experiments after a single and multiple iv administra-tion of cepharanthine,and tissue samples were collected at six different time points(n=6)for the quanti-fication of drug concentrations.④ The whole blood plasma distribution ratio(Rb/p)of cepharanthine hydrochloride(7.5 mg·kg-1)in 3 SD rats was determined 2 h after iv administration.⑤The protein binding of cepharanthine to rat plasma and lung tissue homogenates was determined by equilibrium dialysis before the concentration of the free drug within the lungs was calculated.RESULTS ① An LC-MS/MS method for quantitatively determining cepharanthine in rat plasma and tissue homogenates was devel-oped,which demonstrated an excellent linear relationship(r2>0.999)within the concentration range of 2 to 1000 μg·L-1,with a lower limit of quantification at 2 μg·L-1.The obtained results met all the require-ments for accurate quantitative detection.②The main pharmacokinetic parameters of cepharanthine in rats following a single iv administration were as follows:C0=(686.91±238.43)μg·L-1,t1/2=(29.70±6.29)h,Vz=(62.70±7.93)L·kg-1,Vss=(62.55±11.28)L·kg-1,CL=(1.50±0.23)L·h-1·kg-1 and AUC(0-t)=(4.52±0.61)h·mg·L-1.③ Concentrations in tissues exceeded those in plasma after both a single and multiple iv administration,with the highest levels in the lung.The values of AUC(0-t)in lungs were(2 547.35±156.56)and(4 481.35±479.21)h·mg·L-1 after a single and multiple iv administration,respectively.④ The content of cepharanthine in blood cells was higher than that in plasma,and Rb/p was 3.5±0.8.⑤ After correction by the protein-binding rate,the minimum concentration of free drugs in the lungs(95.04 μg·L-1)exceeded the reported antiviral activity threshold against coronaviruses(EC50=60.67 μg·L-1).CONCLUSION An LC-MS/MS method has been established to rapidly and sensitively determine the concentration of cepharanthine in rat plasma and tissues.Following intravenous administration of ceph-aranthine hydrochloride,the pulmonary exposure level of the drug is significantly higher in plasma and other tissues,providing data for evaluating its in vivo pharmacological activities.

cepharanthine hydrochloride injectionspharmacokineticstissue distributionlung exposureexposure-response relationship

杨增旭、郑博鸿、王梦冉、程凤旭、张文鹏、刘春艳、肖军海、庄笑梅

展开 >

华北理工大学药学院,河北 唐山 063000

军事医学研究院,北京 100850

北京生物制品研究所有限责任公司,北京 100176

盐酸千金藤素注射液 药代动力学 组织分布 肺部暴露 暴露-效应关系

2025

中国药理学与毒理学杂志
军事医学科学院毒物药物研究所,中国药理学会,中国毒理学会

中国药理学与毒理学杂志

北大核心
影响因子:1.182
ISSN:1000-3002
年,卷(期):2025.39(1)